In the medical field, and the medicine and medical device fields (including quasi-pharmaceutical products and cosmetics), based on applicable laws such as the Pharmaceuticals Medical Machinery, etc. Act (previously known as the Pharmaceutical Affairs Act), our Life Science and Healthcare Group offers a variety of legal services to domestic and international clients, including advising on issues regarding licensing, approvals, notifications, etc., compliance, risk management raised by non-compliance, defective product recalls, and information management and intellectual property rights, etc.  In addition, our Life Science and Healthcare Group has undertaken various M&A cases, taking advantage of the group’s broad knowledge, and provided strategic advice.  We provide advice on a broad range of cases, including business mergers, joint ventures, acquisitions, and restructuring among pharmaceutical companies and medical device companies.  We retain an exclusive advisor, Mr. Takahisa Murakami, formerly of the Ministry of Health, Labor and Welfare, and, therefore, are able to advise on the views of jurisdictional authorities.